Literature DB >> 2527294

Prognostic value of ambulatory blood pressure measurements: further analyses.

D Perloff1, M Sokolow, R M Cowan, R P Juster.   

Abstract

The value of ambulatory systolic blood pressure as a predictor of the development of cardiovascular complications was investigated in a sample of 761 hypertensive patients who had undergone ambulatory blood pressure monitoring and who were followed for an average of 5.5 years. Of the 695 patients without prior cardiovascular events at entry into the study, 11% subsequently experienced an event during the follow-up period (up to 10 years) compared to 48% of the 102 patients with a prior cardiovascular event. For each patient, a 'predicted' ambulatory systolic blood pressure was calculated, using the patient's office systolic blood pressure and the equation derived from regressing ambulatory on office blood pressure for the entire sample. By subtracting the predicted from the observed ambulatory pressure, a 'residual' ambulatory systolic blood pressure was derived for each patient, as a measure of that portion of the ambulatory pressure that could not be predicted from the office pressure. We used a Cox proportional hazards model to analyse the independent effect of each of the following patient characteristics at entry on the occurrence of subsequent cardiovascular events: sex, age, ECG evidence of left ventricular hypertrophy, hypertensive retinopathy, ambulatory systolic blood pressure, office systolic blood pressure, residual ambulatory systolic blood pressure and subsequent drug therapy. In both groups, with and without a prior cardiovascular event, women, younger patients and those with lower residual ambulatory systolic blood pressure tended to have longer periods of survival without new cardiovascular events. In the group without prior cardiovascular events, a lower office systolic blood pressure and the absence of advanced ECG evidence of left ventricular hypertrophy were also independently predictive of longer event-free survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2527294

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  19 in total

Review 1.  Chronotherapeutics: are there meaningful differences among antihypertensive drugs?

Authors:  L Poirier; J Lefebvre; Y Lacourciere
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 3.  Ambulatory blood pressure monitoring: a guide for general practitioners.

Authors:  N Prasad; C Isles
Journal:  BMJ       Date:  1996-12-14

4.  Hostility, social support, and ambulatory cardiovascular activity.

Authors:  E G Benotsch; A J Christensen; L McKelvey
Journal:  J Behav Med       Date:  1997-04

5.  Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.

Authors:  Ismail Polat Canbolat; Erdal Belen; Akif Bayyigit; Aysen Helvaci; Kadriye Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

6.  Circadian and circaseptan (about-weekly) aspects of immigrant Indians' blood pressure and heart rate in California, USA.

Authors:  B Sundaram; D C Holley; G Cornélissen; D Naik; R Hanumansetty; R B Singh; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

7.  Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance.

Authors:  W Shamim; M Yousufuddin; D P Francis; P Gualdiero; J W Honour; S D Anker; A J Coats
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

Review 8.  Treatment of white coat hypertension.

Authors:  S G Chrysant
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 9.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

10.  24 hour blood pressure monitoring in healthy and hypertensive children.

Authors:  G S Reusz; M Hóbor; T Tulassay; P Sallay; M Miltényi
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.